David A. Waltz
- The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteersBy Anne Kirsten, Henrik Watz, Frauke Pedersen, Olaf Holz, Rachel Smith, Gerard Bruin, Stephan Koehne-Voss, Helgo Magnussen and David A. WaltzAnne Kirsten*Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Airway Research Center North, Member of the German Center for Lung Research, GrosshansdorfHenrik Watz*Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Airway Research Center North, Member of the German Center for Lung Research, GrosshansdorfFrauke Pedersen*Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Airway Research Center North, Member of the German Center for Lung Research, GrosshansdorfOlaf Holz*Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Airway Research Center North, Member of the German Center for Lung Research, Grosshansdorf#Fraunhofer Institute for Toxicology and Experimental Medicine, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research Hannover, GermanyRachel Smith¶Novartis Institutes for BioMedical Research, Horsham, UKGerard Bruin+Novartis Institutes for BioMedical Research, Basel, SwitzerlandStephan Koehne-Voss+Novartis Institutes for BioMedical Research, Basel, SwitzerlandHelgo Magnussen*Pulmonary Research Institute, Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Airway Research Center North, Member of the German Center for Lung Research, GrosshansdorfDavid A. Waltz§Novartis Institutes for BioMedical Research, Cambridge, MA, USA
- The anti-IL-17A-antibody secukinumab does not attenuate ozone induced acute airway neutrophilia in healthy volunteersBy Anne Kirsten, Henrik Watz, Frauke Pedersen, Olaf Holz, Rachel Smith, Gerard Bruin, Stephan Koehne-Voss, Helgo Magnussen and David A. WaltzAnne Kirsten1PRI, Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Grosshansdorf, GermanyHenrik Watz1PRI, Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Grosshansdorf, GermanyFrauke Pedersen1PRI, Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Grosshansdorf, GermanyOlaf Holz1PRI, Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Grosshansdorf, Germany5ITEM, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyRachel Smith2Novartis Institute for BioMedical Research, Novartis, Horsham, United KingdomGerard Bruin3Novartis Institute for BioMedical Research, Novartis, Basel, SwitzerlandStephan Koehne-Voss3Novartis Institute for BioMedical Research, Novartis, Basel, SwitzerlandHelgo Magnussen1PRI, Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Grosshansdorf, GermanyDavid A. Waltz4Novartis Institute for BioMedical Research, Novartis, Cambridge, MA, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.